Quarterly report pursuant to Section 13 or 15(d)

Consolidated Balance Sheets

v2.4.0.8
Consolidated Balance Sheets (USD $)
Jun. 30, 2013
Dec. 31, 2012
ASSETS    
Cash and cash equivalents $ 11,000 $ 123,000
Inventories 120,000 59,000
Prepaid expenses 0 20,000
Total Current Assets 131,000 202,000
Patents, net 23,000 24,000
Total Other Assets 23,000 24,000
TOTAL ASSETS 154,000 226,000
Current Liabilities:    
Accounts payable 904,000 878,000
Accrued interest 1,430,000 1,253,000
Accrued expenses 1,254,000 1,173,000
Line of credit 0 27,000
Warrant liability 3,000 1,378,000
Settlement note payable 695,000 702,000
Demand notes payable 63,000 63,000
Convertible debentures, net of discount of $347,000 and $809,000, current portion 862,000 463,000
Convertible debentures 547,000 625,000
Total Current Liabilities 5,758,000 6,562,000
Stockholders' Deficit:    
Convertible preferred stock - $0.001 par value; 15,000,000 shares authorized: Series C - 96,230 and 96,230 shares issued and outstanding at June 30, 2013 and December 31, 2012, respectively 1,000 1,000
Series H - 25,000 and 25,000 shares issued and outstanding at June 30, 2013 and December 31, 2012, respectively 0 0
Series I - 1,666,667 and 1,666,667 shares issued and outstanding at June 30, 2013 and December 31, 2012, respectively 2,000 2,000
Common stock - $0.001 par value; 600,000,000 shares authorized; 573,051,524 and 500,573,746 shares issued and outstanding at June 30, 2013 and December 31, 2012, respectively 573,000 501,000
Additional paid-in capital 82,709,000 82,216,000
Accumulated deficit (88,804,000) (88,966,000)
Noncontrolling interest (85,000) (90,000)
Total Stockholders' Deficit (5,604,000) (6,336,000)
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT $ 154,000 $ 226,000